Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialPubMed

Mesenchymal stem cells and their exosomes from umbilical cord and adipose tissue in the prevention of postoperative intra-abdominal adhesions: A rat model study.

Akdemir A., Atay AO., Akman L., Eroglu E., Uyanikgil Y., Tamjidifar R.

Randomized Controlled Trial with a reported sample of 5 on Systemic / IV, published in Int J Biochem Cell Biol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
Int J Biochem Cell Biol (2026)
Country
Netherlands
Reported sample size
5
Source database
PubMed
PMID
41997426
DOI
10.1016/j.biocel.2026.106948

Abstract (original English)

To compare anti-adhesive effects of umbilical cord- and adipose tissue-derived mesenchymal stem cells (MSCs) and their exosomes in a rat model of postoperative intra-abdominal adhesion, and to explore whether responses differ by tissue source and route of administration. Thirty-five female Sprague-Dawley rats were randomly assigned to seven groups (n = 5/group): Group 1, negative control; Group 2, positive control (injury, no treatment); Group 3, UC-MSC; Group 4, UC-MSC-derived exosomes; Group 5, AD-MSC; Group 6, AD-MSC-derived exosomes; and Group 7, intravenous UC-MSC-derived exosomes. Treatments were administered at laparotomy closure. At postoperative week 3, macroscopic adhesion scores were recorded, and peritoneal samples were evaluated for histopathology and immunohistochemical expression of Collagen I, FGF2, VEGF, and HIF-1α. Untreated rats (Group 2) developed severe adhesions with marked tissue thickening, fibrosis, inflammation, and neovascularization, accompanied by increased Collagen I, FGF2, VEGF, and HIF-1α expression (all p < 0.001 vs. control). UC-MSC and AD-MSC treatment (Groups 3, 5) partially attenuated these changes, although fibrosis and extracellular matrix accumulation persisted. Exosome-treated groups (Groups 4, 6, 7) showed more favorable histopathological and immunohistochemical profiles, including lower adhesion thickness and histologic scores, better

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
AnimalsExosomesFemaleMesenchymal Stem CellsTissue AdhesionsAdipose TissueRats, Sprague-DawleyRatsUmbilical CordDisease Models, Animal

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research